Immuneering Corp (IMRX) stock
IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.71+0.04 (+1.09%)
Close on Nov 13, 2026Market cap $240.27MP/E –Yield –
Immuneering enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Immuneering's enterprise value was $180.24M on Nov 11, 2026, against $44.83M a year earlier. Over the last 5 years it ranged from -$81.54M to $250.39M, with a median of $53.58M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $180.24M | +2704.0% |
| 2025 | Dec 31, 2025 | $6.43M | -55.1% |
| 2024 | Dec 31, 2024 | $14.32M | -86.5% |
| 2023 | Dec 29, 2023 | $106.28M | +919.8% |
| 2022 | Dec 30, 2022 | $10.42M | – |
| 2021 | Dec 31, 2021 | -$15.50M | – |
See a number that looks wrong?